H, W., A, R., K, C., K, C., TN, P., SD, W., . . . SK, L. (2026). Peripheral monocyte ratio as a predictive biomarker for metastasis-directed therapy in prostate cancer: Insights from an exploratory study. BMC cancer, 26(1), . https://doi.org/10.1186/s12885-026-15854-1
Chicago Style (17th ed.) CitationH, Wang, et al. "Peripheral Monocyte Ratio as a Predictive Biomarker for Metastasis-directed Therapy in Prostate Cancer: Insights from an Exploratory Study." BMC Cancer 26, no. 1 (2026). https://doi.org/10.1186/s12885-026-15854-1.
MLA (9th ed.) CitationH, Wang, et al. "Peripheral Monocyte Ratio as a Predictive Biomarker for Metastasis-directed Therapy in Prostate Cancer: Insights from an Exploratory Study." BMC Cancer, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12885-026-15854-1.